4//SEC Filing
Dulac Edward J III 4
Accession 0000950170-24-010485
CIK 0001434316other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:09 PM ET
Size
5.4 KB
Accession
0000950170-24-010485
Insider Transaction Report
Form 4
Dulac Edward J III
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-01+425,000→ 425,000 totalExercise: $6.76Exp: 2034-01-31→ Common Stock (425,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2024, such that all of the shares shall be fully vested and exercisable on January 1, 2027, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001821530
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:09 PM ET
- Size
- 5.4 KB